ACHIEVE LIFE SCIENCES ($ACHV) posted quarterly earnings results for Q4 2025 on Tuesday, March 24th. The company reported earnings of -$0.28 per share, missing estimates of -$0.28 by $0.00. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ACHV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ACHIEVE LIFE SCIENCES Hedge Fund Activity
We have seen 48 institutional investors add shares of ACHIEVE LIFE SCIENCES stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 4,346,011 shares (+18747.4%) to their portfolio in Q4 2025, for an estimated $21,599,674
- MILLENNIUM MANAGEMENT LLC added 1,121,614 shares (+472.3%) to their portfolio in Q4 2025, for an estimated $5,574,421
- HEIGHTS CAPITAL MANAGEMENT, INC removed 989,509 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,116,953
- SHAY CAPITAL LLC removed 923,243 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $4,588,517
- CLEARLINE CAPITAL LP removed 451,219 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,242,558
- JANE STREET GROUP, LLC added 382,211 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,899,588
- STONEPINE CAPITAL MANAGEMENT, LLC removed 333,333 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,049,998
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACHIEVE LIFE SCIENCES Analyst Ratings
Wall Street analysts have issued reports on $ACHV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/25/2025
To track analyst ratings and price targets for ACHIEVE LIFE SCIENCES, check out Quiver Quantitative's $ACHV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
